mastodon.world is one of the many independent Mastodon servers you can use to participate in the fediverse.
Generic Mastodon server for anyone to use.

Server stats:

9.2K
active users

#Basilea

0 posts0 participants0 posts today
Grabmacherjoggi Basel<p>100 Jahre Basler Fasnachtsgeschichte: Die aktuelle Plakette und jene von Alfred Seiler aus dem Jahr 1925 (auf der erstmals "Fasnacht" und nicht länger "Fastnacht" zu lesen war).</p><p><a href="https://mas.to/tags/basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basilea</span></a> <a href="https://mas.to/tags/basel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basel</span></a> <a href="https://mas.to/tags/b%C3%A2le" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>bâle</span></a> <a href="https://mas.to/tags/fasnacht" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>fasnacht</span></a></p>
awp<p>Basilea perçoit 1,2 million pour la performance du Cresemba au Japon</p><p>Basilea Pharmaceutica a vu les ventes de son antimycosique Cresemba (isavuconazole) franchir un premier jalon commercial prédéfini au Japon, déclenchant un versement d'étape équivalent à 1,2 million de francs de la part de son partenaire local de distribution Asahi Kasei Pharma (AKP). <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1993165240" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1993165240</span></a></p>
awp<p>Basilea: versements d'étape de plusieurs millions pour Zevtera et Cresemba</p><p>Le laboratoire pharmaceutique Basilea annonce que les ventes de son antifongique Cresemba et de son antibiotique Zevtera ont atteint des seuils l'an dernier lui permettant de recevoir de nouveaux paiements d'étape. Au total, 2,2 millions de francs ont été versés de la part de ses partenaires. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1993498392" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1993498392</span></a></p>
Grabmacherjoggi Basel<p>Klein- und Grossbasel schicken den Widerschein ihrer schimmernden Lichter zum Tanz auf die Wellen hinaus. Dezemberabend am Oberen Rheinweg.</p><p><a href="https://mas.to/tags/basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basilea</span></a> <a href="https://mas.to/tags/basel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basel</span></a> <a href="https://mas.to/tags/basellove" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basellove</span></a> <a href="https://mas.to/tags/lovebasel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>lovebasel</span></a> <a href="https://mas.to/tags/baselcity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>baselcity</span></a> <a href="https://mas.to/tags/baselswitzerland" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>baselswitzerland</span></a></p>
awp<p>Basilea obtient un financement pour développer un antibiotique</p><p>Le laboratoire Basilea a reçu 7,3 millions de dollars de la part du fonds Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) pour développer l'antibiotique BAL2420 et effectuer de premières études cliniques sur l'humain mi-2026. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1994408052" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1994408052</span></a></p>
awp<p>Basilea conclut un accord de commercialisation aux Etats-Unis</p><p>Le laboratoire pharmaceutique Basilea a conclu un accord avec l'américain Innoviva Specialty Therapeutics pour la commercialisation de l'antibiotique Zevtera (ceftobiprole) aux Etats-Unis. Le bâlois recevra un premier versement de 4 millions de dollars (3,5 millions de francs). <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1994645397" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1994645397</span></a></p>
awp<p>Basilea schliesst Lizenzabkommen für Zevtera in den USA mit Innoviva ab</p><p>Basilea hat einen US-Partner für sein Antibiotikum Zevtera (Ceftobiprol) gefunden. Er heisst Innoviva Specialty Therapeutics. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1994645405" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1994645405</span></a></p>
Grabmacherjoggi Basel<p>Die Sonne scheint in den frostig kalten Wintermorgen und küsst wärmend die roten Münstertürme, die stolz über die Dächer der Altstadt ragen. </p><p><a href="https://mas.to/tags/basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basilea</span></a> <a href="https://mas.to/tags/basel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basel</span></a> <a href="https://mas.to/tags/basellove" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basellove</span></a> <a href="https://mas.to/tags/baselswitzerland" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>baselswitzerland</span></a> <a href="https://mas.to/tags/baselcity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>baselcity</span></a> <a href="https://mas.to/tags/switzerland" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>switzerland</span></a></p>
Grabmacherjoggi Basel<p>Die fahle Dezembersonne zieht ihre Bahn am Wolkenhimmel über den Münsterhügel, während ihr Licht eine silberne Spur in die Fluten des Rheins legt.</p><p><a href="https://mas.to/tags/basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basilea</span></a> <a href="https://mas.to/tags/basel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basel</span></a> <a href="https://mas.to/tags/basellove" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>basellove</span></a> <a href="https://mas.to/tags/baselcity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>baselcity</span></a> <a href="https://mas.to/tags/schweiz" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>schweiz</span></a> <a href="https://mas.to/tags/switzerland" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>switzerland</span></a></p>
awp<p>Basilea reçoit un paiement d'étape lié à Cresemba</p><p>Le laboratoire pharmaceutique bâlois Basilea a annoncé jeudi recevoir un nouveau paiement d'étape pour son antifongique Cresemba (isavuconazole). Le partenaire américain de la licence pour la région Asie-Pacifique et la Chine, Pfizer, va verser 1,25 million de dollars (1,1 million en francs). <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1996512983" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1996512983</span></a></p>
awp<p>Basilea erhält Meilensteinzahlung von 1,25 Mio USD dank starker Cresemba-Umsätze</p><p>Das Biopharmaunternehmen Basilea erhält eine weitere Meilensteinzahlung für sein Antimykotikum Cresemba (Isavuconazol). Der Lizenzpartner für die Region Asien-Pazifik und China, der US-Konzern Pfizer, werde 1,25 Millionen US-Dollar zahlen, teilte Basilea am Donnerstag mit. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/Pfizer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Pfizer</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1996513298" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1996513298</span></a></p>
awp<p>Basilea lance une étude de phase 3 sur l'antifongique Fosmanogepix</p><p>Le laboratoire pharmaceutique bâlois Basilea a lancé un essai clinique pour le médicament antifongique Fosmanogepix. Il est destiné au traitement de la candidémie et de la candidose invasive. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1996861904" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1996861904</span></a></p>
awp<p>Basilea obtient des fonds pour développer des médicaments</p><p>Le laboratoire pharmaceutique Basilea a conclu un accord pour développer de nouveaux antifongiques et antibiotiques. Il a obtenu dans ce but un premier versement de 29 millions de dollars de la part de l'organisme public américain Barda, précise jeudi un communiqué de l'entreprise. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1996951246" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1996951246</span></a></p>
awp<p>Basilea perçoit un versement d'étape de 25 millions pour Cresemba</p><p>Basilea Pharmaceutica a perçu un versement d'étape de 25 millions de dollars de la part de Pfizer, liée à la performance de ventes de l'antifongique Cresemba en Europe. Il s'agit du sixième bonus engrangé par le laboratoire rhénan grâce à ce produit depuis le début de l'année. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1997282978" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1997282978</span></a></p>
awp<p>Basilea erhält weitere Meilensteinzahlung für Cresemba</p><p>Das Biopharmaunternehmen Basilea erhält erneut eine Meilensteinzahlung für sein Antipilzmedikament Cresemba. Ausgelöst wurde diese durch starke Umsätze in der Region Europa. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1997283572" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1997283572</span></a></p>
Gianluca Di Marzio 🤖<p><a href="https://twitter.com/hashtag/Udinese" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Udinese</span></a> al lavoro per il sostituto di <a href="https://twitter.com/hashtag/Perez" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Perez</span></a>: offerti 5 milioni per <a href="https://twitter.com/hashtag/VanBreemen" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>VanBreemen</span></a>, il <a href="https://twitter.com/hashtag/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> ne chiede 8</p><p><a href="https://gianlucadimarzio.com/it/udinese-breemen-basilea-news" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="">gianlucadimarzio.com/it/udinese-bre…</span><span class="invisible"></span></a></p>
awp<p>Basilea erhöht nach erstem Semester Ziele für 2024</p><p>Basilea hat sich im ersten Halbjahr 2024 erneut stark entwickelt und ist auch weiterhin profitabel. Für den weiteren Geschäftsverlauf erhöht das Biopharmaunternehmen den Ausblick. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1997783461" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1997783461</span></a></p>
awp<p>Basilea fait le plein de confiance à mi-parcours en 2024</p><p>Le laboratoire Basilea, spécialisé dans les infections mycosiques et bactériennes, relève sensiblement ses ambitions pour l'ensemble de l'exercice en cours au sortir d'un premier semestre nettement plus fructueux que l'an dernier en termes de ventes de produits. Le jeu des paiements d'étapes en revanche a bridé temporairement l'évolution des recettes totales. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1997783467" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1997783467</span></a></p>
awp<p>Basilea a trouvé un repreneur pour un produit expérimental en oncologie</p><p>Basilea a franchi une nouvelle étape dans son désengagement de l'oncologie, avec un accord de cession de la lisavanbuline (BAL101553) à l'organisation américaine à but non lucratif Glioblastoma Foundation. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-1998852185" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-1998852185</span></a></p>
awp<p>Basilea sichert sich Fördergelder für Entwicklung neuer Antibiotika</p><p>Das Biotechunternehmen Basilea hat sich Fördergelder für die Entwicklung einer neuen Antibiotika-Wirkstoffklasse gesichert. <a href="https://awp.news/tags/Basilea" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Basilea</span></a> <a href="https://awp.news/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a></p><p><a href="https://www.awp.ch/sharedarticles?articleid=-2000225803" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">awp.ch/sharedarticles?articlei</span><span class="invisible">d=-2000225803</span></a></p>